Cambridge Investment Research Advisors, Inc.

Position in CORT — Corcept Therapeutics Inc

CIK 1419186 FAIRFIELD, IA

Position in CORT

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$1,723,413

+$549,087 QoQ

Shares Held

42,754

+26.7% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Healthcare · as of Mar 31, 2026

Cambridge Investment Research Advisors, Inc. holds $49,299,867 across 75 Biotechnology names. CORT ranks #8 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,955	$7,124,545
2	EXEL	Exelixis, Inc.	159,749	$6,851,634
3	NKTR	Nektar Therapeutics	56,055	$4,033,157
4	REGN	Regeneron Pharmaceuticals, Inc.	4,832	$3,733,396
5	IBRX	ImmunityBio, Inc.	284,704	$2,183,679
6	BBIO	BridgeBio Pharma, Inc.	29,059	$2,157,921
7	CRSP	CRISPR Therapeutics AG	37,992	$1,807,279
8	CORT	Corcept Therapeutics Inc This page	42,754	$1,723,413

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,723,413	42,754	+26.7%	Shares	Sole	2026-04-30
2025-12-31	$1,174,326	33,745	+125.8%	Shares	Sole	2026-02-05
2025-09-30	$1,241,912	14,943	+45.5%	Shares	Sole	2025-11-12
2025-06-30	$753,964	10,272	-14.4%	Shares	Sole	2025-07-31
2025-03-31	$1,371,211	12,005	-39.3%	Shares	Sole	2025-04-22
2024-12-31	$996,008	19,766	-26.4%	Shares	Sole	2025-02-14
2024-09-30	$1,242,849	26,855	-90.6%	Shares	Sole	2024-10-28
2024-06-30	$9,300,262	286,250	-11.7%	Shares	Sole	2024-07-26
2024-03-31	$8,168,386	324,271	+2922.7%	Shares	Sole	2024-04-24
2023-12-31	$348,445	10,728	-93.8%	Shares	Sole	2024-02-09
2023-09-30	$4,726,567	173,452	-52.6%	Shares	Sole	2023-10-24
2023-03-31	$7,932,325	366,220	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.